Joseph Monahan - Net Worth and Insider Trading

Joseph Monahan Net Worth

The estimated net worth of Joseph Monahan is at least $286,467 dollars as of 2024-11-05. Joseph Monahan is the Chief Scientific Officer of Aclaris Therapeutics Inc and owns about 129,917 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $286,467. Details can be seen in Joseph Monahan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Monahan has not made any transactions after 2023-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joseph Monahan

To

Joseph Monahan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Monahan owns 1 companies in total, including Aclaris Therapeutics Inc (ACRS) .

Click here to see the complete history of Joseph Monahan’s form 4 insider trades.

Insider Ownership Summary of Joseph Monahan

Ticker Comapny Transaction Date Type of Owner
ACRS Aclaris Therapeutics Inc 2023-10-23 Chief Scientific Officer

Joseph Monahan Latest Holdings Summary

Joseph Monahan currently owns a total of 1 stock. Joseph Monahan owns 129,917 shares of Aclaris Therapeutics Inc (ACRS) as of October 23, 2023, with a value of $286,467.

Latest Holdings of Joseph Monahan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACRS Aclaris Therapeutics Inc 2023-10-23 129,917 2.21 286,467

Holding Weightings of Joseph Monahan


Joseph Monahan Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Monahan has made a total of 9 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 6,000 shares on October 23, 2023, which brought Joseph Monahan around $30,480.

Insider Trading History of Joseph Monahan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Monahan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Monahan Ownership Network

Ownership Network List of Joseph Monahan

No Data

Ownership Network Relation of Joseph Monahan

Insider Network Chart

Joseph Monahan Owned Company Details

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Joseph Monahan is the Chief Scientific Officer of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Financial Officer Kevin Balthaser , Chief Business Officer James Loerop , and Pres and COO Douglas J. Manion .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Joseph Monahan made 3 insider transaction in Aclaris Therapeutics Inc (ACRS) with a net sale of 18,000. Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net purchase of 14,705 shares made by James Loerop , and a net purchase of 9,490 shares made by Kevin Balthaser .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aclaris Therapeutics Inc Insider Transactions

No Available Data

Joseph Monahan Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Monahan. You might contact Joseph Monahan via mailing address: C/o Aclaris Therapeutics, Inc., 640 Lee Road, Suite 200, Wayne Pa 19087.